XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income $ 1,023,037 $ 390,982
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 19,127 24,581
Stock-based compensation 487,628 409,840
Unrealized and realized (gain) loss from marketable securities, net 5,005 26,021
Noncash consideration (32,053) (34,789)
Other operating activities 15,833 51,156
Changes in operating assets and liabilities:    
Accounts receivable, net (422,977) (311,699)
Prepaid expenses and other assets 50,343 (15,491)
Accounts payable and accrued liabilities 90,582 49,859
Contract liabilities 160,154 132,340
Other liabilities (39,501) (29,262)
Net cash provided by operating activities 1,357,178 693,538
Investing activities    
Purchases of property and equipment (20,610) (9,528)
Purchases of marketable securities (6,091,513) (3,418,699)
Proceeds from sales and redemption of marketable securities 4,360,327 2,451,378
Purchases of privately-held securities (72,924) (4,000)
Other investing activities (1,000) 0
Net cash used in investing activities (1,825,720) (980,849)
Financing activities    
Proceeds from the exercise of common stock options 120,839 270,207
Repurchases of common stock (55,789) (45,598)
Taxes paid related to net share settlement of equity awards (81,117) 0
Other financing activities 55 91
Net cash provided by (used in) financing activities (16,012) 224,700
Effect of foreign exchange on cash, cash equivalents, and restricted cash 9,444 960
Net decrease in cash, cash equivalents, and restricted cash (475,110) (61,651)
Cash, cash equivalents, and restricted cash - beginning of period 2,119,936 850,107
Cash, cash equivalents, and restricted cash - end of period $ 1,644,826 $ 788,456